Robert W. Baird restated their buy rating on shares of Agilent Technologies (NYSE:A) in a research note issued to investors on Friday, November 24th. Robert W. Baird currently has a $72.00 target price on the medical research company’s stock.
A number of other research firms have also issued reports on A. BidaskClub lowered shares of Agilent Technologies from a strong-buy rating to a buy rating in a report on Saturday, August 12th. Janney Montgomery Scott upped their target price on shares of Agilent Technologies from $65.00 to $70.00 and gave the company a buy rating in a research report on Wednesday, August 16th. J P Morgan Chase & Co reissued an overweight rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, August 16th. Goldman Sachs Group restated a neutral rating and set a $68.00 target price on shares of Agilent Technologies in a research note on Tuesday, September 26th. Finally, Bank of America increased their price target on shares of Agilent Technologies from $66.00 to $68.00 and gave the company an equal weight rating in a research note on Wednesday, August 16th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus target price of $68.34.
Agilent Technologies (A) opened at $65.83 on Friday. The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. Agilent Technologies has a 12-month low of $44.11 and a 12-month high of $70.93. The company has a market cap of $21,317.89, a PE ratio of 27.95, a price-to-earnings-growth ratio of 2.00 and a beta of 1.27.
Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the business earned $0.59 EPS. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. equities research analysts expect that Agilent Technologies will post 2.58 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio is presently 25.24%.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of the company’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jacob Thaysen sold 22,583 shares of the stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $70.41, for a total value of $1,590,069.03. Following the transaction, the senior vice president now directly owns 63,042 shares in the company, valued at approximately $4,438,787.22. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 151,114 shares of company stock valued at $10,359,388.
Several hedge funds have recently made changes to their positions in A. Dupont Capital Management Corp bought a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $101,000. Balentine LLC lifted its position in shares of Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after buying an additional 50 shares during the period. Sun Life Financial INC lifted its position in shares of Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after buying an additional 2,353 shares during the period. Acrospire Investment Management LLC lifted its position in shares of Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after buying an additional 1,200 shares during the period. Finally, Parallel Advisors LLC increased its holdings in Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 131 shares in the last quarter.
TRADEMARK VIOLATION NOTICE: “Robert W. Baird Reaffirms Buy Rating for Agilent Technologies (NYSE:A)” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://ledgergazette.com/2017/12/06/agilent-technologies-a-buy-rating-reiterated-at-robert-w-baird.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.